It is unlikely, therefore, that the failure of CETP to alter TG metabolism in the absence of LDLR was because mouse physiology cannot accommodate further worsening of dyslipidemia beyond that seen with deletion of LDLR. The gene discussed is CETP; the disease is metabolic syndrome.